SEC Form 4 · accession 0001209191-18-035197
Krystal Biotech, Inc. · KRYS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Dino A Rossi
Director
Period of report
May 31, 2018
Accepted (ET)
Jun 4, 2018 · 4:53 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001711279
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $10.29 | May 31, 2018 | A | 7,500 | A | — | May 31, 2028 | Common Stock | 7,500 | 7,500 | D |
Explanation of responses
- F1The options were awarded on May 31, 2018 and vest monthly over a one-year period.